CTOs on the Move

Maitri Health

www.maitrihealth.ca

 
Maitri Health Technologies (CSE:MTEC) is a global platform for healthcare supply security. Our mission is to enhance safety and quality of life, and keep organizations and economies running. Maitri provides a reliable source of innovative, certified personal protective equipment (PPE) and testing solutions through an onshore manufacturing model. Our stable, scalable supply chain is integrated with unique digital technology to deliver a comprehensive healthcare supply platform.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Andrew McCann
Chief Technology Officer Profile

Similar Companies

Center for Advanced Medical Education

Center for Advanced Medical Education, Inc. is a Lambertville, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Upsher-Smith Laboratories, Inc.

Upsher-Smith Laboratories, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Maple Grove, MN. To find more information about Upsher-Smith Laboratories, Inc., please visit www.upsher-smith.com

The Washington Home

The Washington Home is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. The Washington Home is based in Hagerstown, MD. You can find more information on The Washington Home at www.thewashingtonhome.org

Avera Queen of Peace Health Services

Avera Queen of Peace Health Services is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Mitchell, SD. To find more information about Avera Queen of Peace Health Services, please visit www.averaqueenofpeace.org

Geron

We are a biopharmaceutical company developing first-in-class therapies for cancer. Imetelstat, a novel, first-in-class telomerase inhibitor, is our product candidate in clinical development. Telomerase enables cancer cells to maintain telomere length, which provides them with the capacity for limitless cellular replication. Imetelstat is a potent and specific inhibitor of telomerase. Based on clinical data we obtained in late 2012, we may develop imetelstat to treat one or more hematologic myeloid malignancies such as myelofibrosis, or MF, myelodysplastic syndromes, or acute myelogenous leukemia.